Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001493152-22-008423
Filing Date
2022-03-31
Accepted
2022-03-31 16:01:52
Documents
1
Period of Report
2021-12-31
Effectiveness Date
2022-03-31

Document Format Files

Seq Description Document Type Size
1 formnt10-k.htm NT 10-K 29567
  Complete submission text file 0001493152-22-008423.txt   30902
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-12555 | Film No.: 22792280
SIC: 7389 Services-Business Services, NEC